NewLink Genetics Presents Encouraging Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019

NEXT STORY
Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
PREV STORY
Expanded MS1819-SD Global Commercialization Rights Now Owned by AzurRx BioPharma along with Full Development Rights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global POC Molecular Diagnostics Market (2020 to 2024) – Featuring Abbott Laboratories, BioFire Diagnostics & bioMerieux Among Others

author_avatar
NASDAQ Market News

AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal muscular atrophy (SMA)

author_avatar
NASDAQ Market News

NANOBIOTIX successfully completes approx. EUR 25.1 million private placement of new shares

Not for release, publication or distribution, directly or indirectly, in or into the United ...

author_avatar
NASDAQ Market News